Psychostic disorder as the first manifestation of myxedema: A case report

Article Sidebar

PDF (Español (España)) HTML (Español (España))
Published: Feb 29, 2024
DOI: https://doi.org/10.21676/2389783X.5469
Keywords:
Hypothyroidism, Myxedema, Psychotic disorders, Thyroid diseases
Psychostic disorder as the first manifestation of myxedema: A case report

Main Article Content

Carlos Arturo Cassiani-Miranda
Universidad de Santander
Eduard Pérez-Anibal
Universidad de Cartagena
Johan Danilo-Torres
Universidad de Santander
Alexander Blanco-Palomino
Universidad Industrial de Santander

Abstract

Myxedema coma is severe and life-threatening. This condition represents a state of long-lasting, unrecognized or poorly controlled thyroid hypofunction. Occasionally these patients first receive a diagnosis of a mental disorder. A case of acute psychosis is presented in a 51-year-old woman, with no history of mental disorder as the initial manifestation of myxedema. In patients with acute psychosis, evaluation of thyroid function is imperative. Treatment includes thyroid hormone replacement and short-term antipsychotics. It is crucial to consider thyroid etiology in cases of acute psychoses.

Downloads

Download data is not yet available.

Article Details

How to Cite
Cassiani-Miranda, C. A., Pérez-Anibal, E., Danilo-Torres, J. ., & Blanco-Palomino, A. (2024). Psychostic disorder as the first manifestation of myxedema: A case report. Duazary, 20(4), 296–302. https://doi.org/10.21676/2389783X.5469
Issue
Vol. 20 No. 4 (2023): (October - December)
Section
Clinical report
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Commercial use of the original work or of possible derivative works is not allowed, the distribution of which must be done with a license equal to that which regulates the original work.
 
 
 
 

References

Klubo-Gwiezdzinska J, Wartofsky L. Thyroid emergencies. Med Clin North Am. 2012;96(2):385-403. http://dx.doi.org/10.1016/j.mcna.2012.01.015

Rodríguez I, Fluiters E, Pérez-Méndez LF, Luna R, Páramo C, García-Mayor RV. Factors associated with mortality of patients with myxoedema coma: Prospective study in 11 cases treated in a single institution. J Endocrinol. 2004;180(2):347-350. http://dx.doi.org/10.1677/joe.0.1800347

Ono Y, Ono S, Yasunaga H, Matsui H, Fushimi K, Tanaka Y. Clinical characteristics and outcomes of myxedema coma: Analysis of a national inpatient database in Japan. J Epidemiol. 2017;27(3):117-122. http://dx.doi.org/10.1016/j.je.2016.04.002

Chiong YV, Bammerlin E, Mariash CN. Development of an objective tool for the diagnosis of myxedema coma. Transl Res. 2015;166(3):233-243. http://dx.doi.org/10.1016/j.trsl.2015.01.003

Heinrich TW, Grahm G. Hypothyroidism presenting as psychosis: myxedema madness revisited. Prim Care Companion J Clin Psychiatry. 2003;5(6):260-266. http://dx.doi.org/10.4088/pcc.v05n0603

Azzopardi L, Murfin C, Sharda A, De Silva N. Myxoedema madness. BMJ Case Rep. 2010;1-3. http://dx.doi.org/10.1136/bcr.03.2010.2841

Pomeranze J, King E. Psychosis as first sign of thyroid dysfunction. Geriatrics. 1966;21(6):211-212. http://dx.doi.org/10.4088/pcc.v05n0603

Ueno S, Tsuboi S, Fujimaki M, Eguchi H, Machida Y, Hattori N, et al. Acute psychosis as an initial manifestation of hypothyroidism: A case report. J Med Case Rep. 2015;9(1):1-3. http://dx.doi.org/10.1186/s13256-015-0744-z

Chaker L, Bianco AC, Jonklaas J, Peeters RP. Hypothyroidism. Lancet. 2017;390(10101):155-1562. http://dx.doi.org/10.1016/S0140-6736(17)30703-1

Morosán-Allo YJ, Rosmarin M, Urrutia A, Faingold MC, Musso C, Brenta G. Myxedema madness complicating postoperative follow-up of thyroid cancer. Arch Endocrinol Metab. 2015;59(4):359-363. http://dx.doi.org/10.1590/2359-3997000000090

Feldman AZ, Shrestha RT, Hennessey J V. Neuropsychiatric Manifestations of thyroid disease. Endocrinol Metab Clin North Am. 2013;42(3):453-476. http://dx.doi.org/10.1016/j.ecl.2013.05.005

Sardar S, Habib MB, Sukik A, Tanous B, Mohamed S, Tahtouh R et al. Myxedema Psychosis: Neuropsychiatric manifestations and rhabdomyolysis unmasking hypothyroidism. Case Rep Psychiatry. 2020;2020:7801953. http://dx.doi.org/10.1155/2020/7801953

Van Vliet NA, Van Heemst D, Almeida OP, Åsvold BO, Aubert CE, Bae JB, et al. Thyroid studies collaboration. Association of thyroid dysfunction with cognitive function: An individual participant data analysis. JAMA Intern Med. 2021;181(11):1440-1450. http://dx.doi.org/ 10.1001/jamainternmed.2021.5078.

Fernández-Lamo I, Montero-Pedrazuela A, Delgado-García JM, Guadaño-Ferraz A, Gruart A. Effects of thyroid hormone replacement on associative learning and hippocampal synaptic plasticity in adult hypothyroid rats. Eur J Neurosci. 2009;30(4):679-692. http://dx.doi.org/10.1111/j.1460-9568.2009.06862.x

Koromilas C, Liapi C, Schulpis KH, Kalafatakis K, Zarros A, Tsakiris S. Structural and functional alterations in the hippocampus due to hypothyroidism. Metab Brain Dis. 2010;25(3):339-354. http://dx.doi.org/10.1007/s11011-010-9208-8

Mavroson MM, Patel N, Akker E. Myxedema psychosis in a patient with undiagnosed hashimoto thyroiditis. J Am Osteopath Assoc. 2017;117(1):50-54. http://dx.doi.org/10.7556/jaoa.2017.007

Hawatmeh A, Thawabi M, Abuarqoub A, Shamoon F. Amiodarone induced myxedema coma: Two case reports and literature review. Heart Lung. 2018;47(4):429-431. http://dx.doi.org/10.1016/j.hrtlng.2018.03.012

Ylli D, Klubo‑Gwiezdzinska J, Wartofsky L. Thyroid emergencies. Polish Arch Intern Med. 2019;129(7–8):526-534. http://dx.doi.org/10.20452/pamw.14876

Popoveniuc G, Chandra T, Sud A, Sharma M, Blackman MR, Burman KD, et al. A diagnostic scoring system for myxedema coma. Endocr Pract. 2014;20(8):808-817. http://dx.doi.org/10.4158/EP13460.OR

Kwaku MP, Burman KD. Myxedema coma. J Intensive Care Med. 2007;22(4):224-231. http://dx.doi.org/10.1177/0885066607301361

Most read articles by the same author(s)